Lipocine (LPCN) Cash from Financing Activities (2011 - 2025)
Lipocine (LPCN) reported Cash from Financing Activities of $141,334 for Q3 2025.
Powered by 
Analysis
Lipocine (LPCN) Cash from Financing Activities (2011 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Lipocine's Cash from Financing Activities came in at $358,774, up 75.8% year-over-year; for FY2024, it came in at $209,340, down 48.3% from FY2023.
- Cash from Financing Activities has a five-year compound annual growth rate of -54.1% (FY2019 to FY2024).
- By year, Cash from Financing Activities came in at $404,567 in FY2023, -$2.13 million in FY2022, $26.92 million in FY2021 (+28.8%) and $20.9 million in FY2020 (+102.5%).
- The Q3 2025 figure ranks as the highest quarterly Cash from Financing Activities since Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Lipocine | 11.92 Mn | -55.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 141,334.00 |
| Jun 30, 2024 | 217,440.00 |
| Mar 31, 2024 | -8,100.00 |
| Dec 31, 2023 | -5,299.00 |
| Sep 30, 2023 | 421,082.00 |
| Jun 30, 2023 | -5,200.00 |
| Mar 31, 2023 | -6,016.00 |
| Dec 31, 2022 | -5,900.00 |
| Sep 30, 2022 | 44.00 |
| Jun 30, 2022 | -1.49 Mn |
| Mar 31, 2022 | -627,346.00 |
| Dec 31, 2021 | -838,463.00 |
| Sep 30, 2021 | -838,265.00 |
| Jun 30, 2021 | -838,609.00 |
| Mar 31, 2021 | 29.44 Mn |
| Dec 31, 2020 | 4.56 Mn |
| Sep 30, 2020 | 4.66 Mn |
| Jun 30, 2020 | 6.80 Mn |
| Mar 31, 2020 | 4.88 Mn |
| Dec 31, 2019 | 5.81 Mn |
API Access
Lipocine Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();